Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023048 · ClinicalTrials.gov registry record · NA
Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)
A NA study, sponsored by Natera.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT01023048 is a NA study that has completed, run by Natera. The registered enrollment target is 56 participants.
The verdict
NCT01023048, a NA study, has completed, sponsored by Natera.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
Gene Security Network has developed a novel technology called Parental SupportTM (PS) which is used for Preimplantation Genetic Screening/Diagnosis (PGS/D) during in vitro fertilization (IVF). This technology allows IVF physicians to identify embryos, prior to transfer to the uterus, which have the best chance of developing into healthy children. The purpose of this study is to validate clinical use of PS to detect specific genetic mutation(s) known to cause severe inheritable diseases in embryos produced by at-risk couples. This may be done while simultaneously testing these embryos for aneuploidy. This study will allow for first of its kind commercial PGS/D testing to detect disease-associated genetic mutations together with aneuploidy screening.
Interventions
- OTHER preimplantation diagnosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2009-11 |
| Est. Completion | 2014-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01023048
The ClinicalTrials.gov registry entry for NCT01023048 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Natera, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which preimplantation diagnosis is the first listed.
NCT01023048 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01023048 about?
NCT01023048 is a clinical study titled "Concurrent Single Gene and 24 Chromosome Aneuploidy Preimplantation Genetic Diagnosis (PGD)". Gene Security Network has developed a novel technology called Parental SupportTM (PS) which is used for Preimplantation Genetic Screening/Diagnosis (PGS/D) during in vitro fertilization (IVF). This technology allows IVF physicians to identify embryos, prior to transfer to the uterus, which have the ...
What is the current status of trial NCT01023048?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2009-11. Estimated completion is 2014-03.
What interventions are being tested in trial NCT01023048?
The interventions under investigation include: preimplantation diagnosis (OTHER).
Who is sponsoring clinical trial NCT01023048?
This trial is sponsored by Natera, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.